Celcuity Inc. (CELC) Financials

CELC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 142.4 million 49.5 million
2023-06-30 153.5 million 43.4 million
2023-03-31 164.9 million 41.6 million
2022-12-31 175.7 million 41.9 million

CELC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -12.8 million 1.1 million
2023-06-30 -9.7 million 1.3 million
2023-03-31 -12.9 million 1.3 million
2022-12-31 -9.6 million 1.1 million

CELC Net Income

No data available :(

CELC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 133.9 million - 459025
2023-06-30 146.2 million 36.0 million 508453
2023-03-31 157.5 million 35.5 million 559837
2022-12-31 168.6 million 35.0 million 255200

CELC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 22.1 million
2023-06-30 22.0 million
2023-03-31 21.7 million
2022-12-31 16.9 million

CELC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 53104 17.5 million 1.4 million -
2023-06-30 4854 13.7 million 1.3 million -
2023-03-31 6987 11.3 million 1.3 million -
2022-12-31 112044 10.6 million 1.0 million -

CELC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 33555
2023-06-30 - 37331
2023-03-31 - 43938
2022-12-31 - 48937

CELC

Price: $17.66

52 week price:
8.39
22.19

Earnings Per Share: -2.74 USD

P/E Ratio: -5.28

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 28600

Market Capitalization: 499.2 million

Links: